We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.4%
2 Technology 3.32%
3 Consumer Discretionary 2.87%
4 Financials 2.84%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMLP
8976
PUT
DELISTED
Golar LNG Partners LP
GMLP
$72K ﹤0.01%
27,900
-10,400
-27% -$26.3K
ACR
8977
PUT
ACRES Commercial Realty
ACR
$124M
$71K ﹤0.01%
+8,933
New +$68K
AVXL icon
8978
Anavex Life Sciences
AVXL
$255M
$71K ﹤0.01%
14,338
-7,886
-35% -$29.8K
GNPX icon
8979
Genprex
GNPX
$3.02M
$71K ﹤0.01%
1
LSTA icon
8980
CALL
Lisata Therapeutics
LSTA
$9.02M
$71K ﹤0.01%
+2,673
New +$78.6K
TZOO icon
8981
PUT
Travelzoo
TZOO
$74.3M
$71K ﹤0.01%
+12,600
New +$69.5K
VRAY
8982
PUT
DELISTED
ViewRay, Inc.
VRAY
$71K ﹤0.01%
31,800
-500
-2% -$1.07K
ASAP
8983
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$71K ﹤0.01%
1,358
-3,010
-69% -$116K
MR
8984
DELISTED
Montage Resources Corporation Common Stock
MR
$71K ﹤0.01%
17,948
-54,203
-75% -$277K
MFGP
8985
PUT
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$71K ﹤0.01%
12,900
DLNG icon
8986
PUT
Dynagas LNG Partners
DLNG
$132M
$70K ﹤0.01%
21,900
+2,500
+13% +$4.92K
SLNO
8987
PUT
DELISTED
Soleno Therapeutics
SLNO
$70K ﹤0.01%
+2,107
New +$91.3K
XNET
8988
CALL
Xunlei
XNET
$340M
$70K ﹤0.01%
20,100
+8,900
+79% +$30.4K
LGF.B
8989
CALL
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$70K ﹤0.01%
10,300
+200
+2% +$1.38K
KIN
8990
CALL
DELISTED
Kindred Biosciences, Inc.
KIN
$70K ﹤0.01%
+15,600
New +$69.7K
CDMO
8991
PUT
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$69K ﹤0.01%
+10,500
New +$58.6K
VVNT.WS
8992
DELISTED
Vivint Smart Home, Inc. Warrants, each exercisable for one Class A Common Stock at an exercise price
VVNT.WS
$69K ﹤0.01%
12,070
-1,551
-11% -$3.25K
ABEO icon
8993
PUT
Abeona Therapeutics
ABEO
$366M
$68K ﹤0.01%
932
-196
-17% -$13.5K
INVE icon
8994
CALL
Identive
INVE
$63.4M
$68K ﹤0.01%
+13,300
New +$52.6K
IMDX
8995
Insight Molecular Diagnostics
IMDX
$150M
$68K ﹤0.01%
1,781
+648
+57% +$33.5K
PSEC icon
8996
Prospect Capital
PSEC
$1.07B
$68K ﹤0.01%
13,266
STGW icon
8997
CALL
Stagwell
STGW
$2.07B
$68K ﹤0.01%
+32,700
New +$43.5K
OBSV
8998
DELISTED
ObsEva SA Ordinary Shares
OBSV
$68K ﹤0.01%
11,613
-1,037
-8% -$3.91K
HYRE
8999
PUT
DELISTED
HyreCar Inc. Common Stock
HYRE
$68K ﹤0.01%
23,100
+6,500
+39% +$13.5K
BGC icon
9000
CALL
BGC Group
BGC
$5.45B
$67K ﹤0.01%
24,400
-1,800
-7% -$4.99K

Similar funds

Citadel Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.

  • Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
  • Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.